PRETERM DELİVERY and MYOCINE BINDING PROTEIN C LEVELs
Can First Trimester Serum Myocine Binding Protein c Level Predict Preterm Birth
1 other identifier
observational
90
1 country
1
Brief Summary
IT WAS AIMED TO EVALUATE IF MBPC CAN BE USED IN PREDICTION OF EARLY BIRTH. TAKING THE FIRST TRIMESTER FROM PREGNANCY WAS STORED UNTIL THE TIMING OF DELIVERY.THE PARTICIPANTS WERE SEPARATED INTO TWO GROUPS ACCORDING TO THE TIME OF BIRTH, EARLY AND TIMELY. SERUM MBPC LEVELS BETWEEN TWO GROUPS EVALUATED.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 22, 2022
CompletedFirst Posted
Study publicly available on registry
August 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedNovember 23, 2022
November 1, 2022
10 months
August 22, 2022
November 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
detection of prediction value of serum mbpc levels in preterm delivery
identifying prediction value of first trmester serum mbpc levels by comparing by serum levels of mbpc in groups
10 mounths
Study Arms (2)
women who gave birth prematurely
women who had serum taken in the first trimester and gave birth earlier than 37 weeks according to the time of delivery
those who gave birth on time
women who have had serum taken in the first trimester, stored and delivered on time
Interventions
Serum samples will be taken from the participants in the first trimester, transferred to eppendorf tubes after appropriate procedures, and stored at -80 degrees until the time of deliveryParticipants will be divided into two groups according to the timing of birthThe first group is those who gave birth earlier than 37 weeks those who gave birth on time in the other group The mbpc levels will be looked at and compared.
Eligibility Criteria
Includes participants whose serum samples were collected in the first trimester, stored, and then divided into two according to timing of delivery fırst grup ıs preterm group, and second one ıs those who gave birth on time
You may qualify if:
- being pregnant in the first trimester
- be between 18-40 years old
You may not qualify if:
- no history of preterm birth
- being pregnant with assisted reproductive techniques
- having a multiple pregnancy
- have cervical insufficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziosmanpasa Training and Research Hospital
Istanbul, Gaziosmanpaşa, 32225, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
elif yıldız
Gaziosmanpasa Research and Education Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MEDİCAL DOCTOR
Study Record Dates
First Submitted
August 22, 2022
First Posted
August 24, 2022
Study Start
January 1, 2022
Primary Completion
October 30, 2022
Study Completion
October 30, 2022
Last Updated
November 23, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share